My Ozempic

I’m on Ozempic for quite a few months now and the only side affect I have is being randomly sick.

Bluemic said:

I’m on metformin and will be given my first dosage of Ozempic.. I’ve read so much about Ozempic that I’m still not sure how I will cope with the side effects. I’m dreading the impact it will have on daily life.
I understand that it will be given on a weekly bases. But I’m not looking forward to the jab even though it’s only just under the skin.

I understand that the overall effect is a good one and I’m hoping that the majority of Ozempic users are more than glad to share their opinions but I still have my doubts because I have poor k function. Which is a great concern to me.
Your feedback will be greatly appreciated.

Click to expand...

Hi. Has Ozempic been prescribed for weight reduction? Have you tried a low-carb diet prior to this?

https://www.webmd.com/drugs/2/drug-174491/ozempic-subcutaneous/details/list-contraindications
Weak kidney function is one contra-indication., but there are studies that claim Ozempic is benficial for kidney function. Jury seems to be out still.

Been on ozempic 1 ml dose for 6 weeks. I have diabetes 2 which was under control. My GP put me on it as I'm overweight. In that time I have lost over 11.7 kgs . I have several side affects in first 5 weeks .diarrhea. feel sick like going to vomit . Still have diarrhea but rest of side affects are gone. Take a while for your system to get use too I was told . Can be different side affects and length they last is different for everyone. For me it's worth it but it's hard in beginning.

Oldvatr said:

https://www.webmd.com/drugs/2/drug-174491/ozempic-subcutaneous/details/list-contraindications
Weak kidney function is one contra-indication., but there are studies that claim Ozempic is benficial for kidney function. Jury seems to be out still.

Click to expand...

Then again there is this

"
Semaglutide markedly improves albuminuria and other important renal and metabolic parameters in patients with diabetic kidney disease (DKD) at high risk for progression, according to real-world data presented at the 58th European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Congress.

Investigators studied 122 patients with an estimated glomerular filtration rate (eGFR) higher than 15 but less than 60 mL/min/1.73 m2 or urinary albumin to creatinine ratio (UACR) exceeding 30 mg/g treated with semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Over 12 months, semaglutide significantly decreased mean UACR by 53%, from 349.5 to 187.3 mg/g, Beatriz Avilés, MD, PhD, of Hospital Costa del Sol in Málaga, Spain, and colleagues reported. Mean eGFR remained relatively stable with a slight increase of 2.2 mL/min/1.73 m2."